Dabrafenib; Preclinical Characterization, Increased Efficacy when Combined with Trametinib, while BRAF/MEK Tool Combination Reduced Skin Lesions

por King, Alastair J., Arnone, Marc R., Bleam, Maureen R., Moss, Katherine G., Yang, Jingsong, Fedorowicz, Kelly E., Smitheman, Kimberly N., Erhardt, Joseph A., Hughes-Earle, Angela, Kane-Carson, Laurie S., Sinnamon, Robert H., Qi, Hongwei, Rheault, Tara R., Uehling, David E., Laquerre, Sylvie G.
Publicado 2013